SE9402510D0 - Process for synthesis of substituted 2-(2-pyridinylmethylsulphinyl)-1H-benzimidazoles - Google Patents
Process for synthesis of substituted 2-(2-pyridinylmethylsulphinyl)-1H-benzimidazolesInfo
- Publication number
- SE9402510D0 SE9402510D0 SE9402510A SE9402510A SE9402510D0 SE 9402510 D0 SE9402510 D0 SE 9402510D0 SE 9402510 A SE9402510 A SE 9402510A SE 9402510 A SE9402510 A SE 9402510A SE 9402510 D0 SE9402510 D0 SE 9402510D0
- Authority
- SE
- Sweden
- Prior art keywords
- pct
- benzimidazoles
- date
- sec
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (43)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9402510A SE504459C2 (sv) | 1994-07-15 | 1994-07-15 | Förfarande för framställning av substituerade sulfoxider |
SI9530676T SI0773940T2 (sl) | 1994-07-15 | 1995-07-03 | Postopek za sintezo substituiranih sulfoksidov |
EP95926068A EP0773940B2 (en) | 1994-07-15 | 1995-07-03 | Process for synthesis of substituted sulphoxides |
US08/492,087 US5948789A (en) | 1994-07-15 | 1995-07-03 | Process for synthesis of substituted sulphoxides |
KR1019970700221A KR100356252B1 (ko) | 1994-07-15 | 1995-07-03 | 치환술폭시드의합성방법 |
SK48-97A SK284059B6 (sk) | 1994-07-15 | 1995-07-03 | Spôsob prípravy substituovaných sulfoxidov |
AT95926068T ATE242233T1 (de) | 1994-07-15 | 1995-07-03 | Verfahren zur herstellung von substituierten sulfoxiden |
PCT/SE1995/000818 WO1996002535A1 (en) | 1994-07-15 | 1995-07-03 | Process for synthesis of substituted sulphoxides |
DE69530987T DE69530987T3 (de) | 1994-07-15 | 1995-07-03 | Verfahren zur herstellung von substituierten sulfoxiden |
ES95926068T ES2199998T5 (es) | 1994-07-15 | 1995-07-03 | Procedimiento para la síntesis de sulfóxidos sustituidos. |
CA002193994A CA2193994C (en) | 1994-07-15 | 1995-07-03 | Process for synthesis of substituted sulphoxides |
UA97020638A UA47409C2 (uk) | 1994-07-15 | 1995-07-03 | Спосіб синтезу заміщених сульфоксидів (варіанти) та сульфоксид |
EE9700006A EE03354B1 (et) | 1994-07-15 | 1995-07-03 | Asendatud sulfoksiidide sünteesi protsess |
MX9700358D MX9700358A (es) | 1994-07-15 | 1995-07-03 | Proceso par a la sintesis de sulfoxidos substituidos. |
BR9508292A BR9508292A (pt) | 1994-07-15 | 1995-07-03 | Processos para a sintese enãncio-seletiva de um composto,(-)-5-metóxi-2[[(4-metóxi-3,5-dimetil-2-piridinil) metil]sulfinil]-1h-benzimidazol,(+)-5-fluoro-2-(((4-ciclopropilmetóxi-2-piridinil) metil) sulfinil)-1h-benzimidazol,(-)-5-fluoro-2-(((4-ciclopropilmetóxi-2-piridinil) metil) sulfinil)-1h-benzimidazol,(-)-5-fluoro-2-(((4-ciclopropilmetóxi-2-piridinil) metil) sulfinil)-1h-benzimidazol,(-)-5-carbometóxi-6-metil-2-[[(3,4-dimetóxi-2-piridinil) metil] sulfinil]-1h-benzimidazol,(+)-5-carbometóxi-6-metil-2-[[(3,4-dimetóxi-2-piridinil) metil] sulfinil]-1h benzimidazol composto e uso dos compostos |
PT95926068T PT773940E (pt) | 1994-07-15 | 1995-07-03 | Processo de sintese de sulfoxidos substituidos |
DK95926068.8T DK0773940T4 (da) | 1994-07-15 | 1995-07-03 | Fremgangsmåde til syntese af substituerede sulfoxider |
AU29948/95A AU688074B2 (en) | 1994-07-15 | 1995-07-03 | Process for synthesis of substituted sulphoxides |
JP50493896A JP3795917B2 (ja) | 1994-07-15 | 1995-07-03 | 置換スルホキシドの合成法 |
RU97102162/04A RU2157806C2 (ru) | 1994-07-15 | 1995-07-03 | Способы синтеза замещенных сульфоксидов |
TW084106875A TW372971B (en) | 1994-07-15 | 1995-07-04 | Process for synthesis of substituted sulphoxides |
HU9700108A HU226361B1 (en) | 1994-07-15 | 1995-07-05 | Process for synthesis of substituted sulphoxides |
CZ0006497A CZ297987B6 (cs) | 1994-07-15 | 1995-07-05 | Zpusob prípravy substituovaných sulfoxidu |
CN95194956A CN1070489C (zh) | 1994-07-15 | 1995-07-05 | 取代的亚砜类化合物的合成方法 |
PL95318165A PL186342B1 (pl) | 1994-07-15 | 1995-07-05 | Sposób enancjoselektywnej syntezy związku sulfotlenkowego |
NZ289959A NZ289959A (en) | 1994-07-15 | 1995-07-05 | Process for enantioselective synthesis of substituted 2-[(2-pyridinyl(or phenyl)methyl)sulphinyl]-1h-[benzimidazole (or thienoimidazole)] (including omeprazole) and other structurally related suphoxides and salts thereof |
IL11447795A IL114477A (en) | 1994-07-15 | 1995-07-06 | A process for the enantioselective synthesis of converted sulfoxides, individual enantiomers obtained as a result of the process and their use in the preparation of drugs |
MA23950A MA23611A1 (fr) | 1994-07-15 | 1995-07-10 | Procede pour la synthese de sulfoxydes substitues |
ZA955724A ZA955724B (en) | 1994-07-15 | 1995-07-10 | Process for synthesis of substituted sulphoxides |
DZ950088A DZ1911A1 (fr) | 1994-07-15 | 1995-07-11 | Procédé pour la synthèse de sulfoxydes substitues. |
EG57195A EG24534A (en) | 1994-07-15 | 1995-07-11 | Process for synthesis of substituted sulfoxides |
HR950401A HRP950401B1 (en) | 1994-07-15 | 1995-07-12 | Process for synthesis of substituted sulphoxides |
TNTNSN95081A TNSN95081A1 (fr) | 1994-07-15 | 1995-07-13 | Procede pour la synthese de sulfoxydes substitues |
MYPI95001998A MY113180A (en) | 1994-07-15 | 1995-07-14 | Process for synthesis of substituted sulfoxides |
YU47695A YU49475B (sh) | 1994-07-15 | 1995-07-14 | Postupak za sintezu supstituisanih sulfoksida |
TR95/00861A TR199500861A2 (tr) | 1994-07-15 | 1995-07-14 | Ikame edilmis sulfoksidlerin sentezi icin proses. |
SA95160294A SA95160294B1 (ar) | 1994-07-15 | 1995-10-07 | عملية لتحضير synthesisمركبات سلفوكسيد مستبدلة substituted sulphoxide |
ARP960103398A AR003443A1 (es) | 1994-07-15 | 1996-06-28 | Procedimiento para la purificacion optica de preparaciones enantiomericamente enriquecidas de compuestos derivados de 2-sulfinil-bencimidazol |
IS4406A IS1772B (is) | 1994-07-15 | 1996-12-27 | Aðferð við myndun útskiptra súlfoxíða |
FI970102A FI117672B (sv) | 1994-07-15 | 1997-01-10 | Förfarande för syntetisering av substituerade sulfoxider |
FI970102D FI117830B (sv) | 1994-07-15 | 1997-01-10 | Förfarande för syntetisering av substituerade sulfoxider |
NO19970153A NO312101B1 (no) | 1994-07-15 | 1997-01-14 | Fremgangsmåte for syntese av substituerte sulfoksider, og slike produktforbindelser |
HK98109230A HK1008331A1 (en) | 1994-07-15 | 1998-07-17 | Process for synthesis of substituted sulphoxides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9402510A SE504459C2 (sv) | 1994-07-15 | 1994-07-15 | Förfarande för framställning av substituerade sulfoxider |
Publications (3)
Publication Number | Publication Date |
---|---|
SE9402510D0 true SE9402510D0 (sv) | 1994-07-15 |
SE9402510L SE9402510L (sv) | 1996-01-16 |
SE504459C2 SE504459C2 (sv) | 1997-02-17 |
Family
ID=20394753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9402510A SE504459C2 (sv) | 1994-07-15 | 1994-07-15 | Förfarande för framställning av substituerade sulfoxider |
Country Status (42)
Country | Link |
---|---|
US (1) | US5948789A (sv) |
EP (1) | EP0773940B2 (sv) |
JP (1) | JP3795917B2 (sv) |
KR (1) | KR100356252B1 (sv) |
CN (1) | CN1070489C (sv) |
AR (1) | AR003443A1 (sv) |
AT (1) | ATE242233T1 (sv) |
AU (1) | AU688074B2 (sv) |
BR (1) | BR9508292A (sv) |
CA (1) | CA2193994C (sv) |
CZ (1) | CZ297987B6 (sv) |
DE (1) | DE69530987T3 (sv) |
DK (1) | DK0773940T4 (sv) |
DZ (1) | DZ1911A1 (sv) |
EE (1) | EE03354B1 (sv) |
EG (1) | EG24534A (sv) |
ES (1) | ES2199998T5 (sv) |
FI (2) | FI117830B (sv) |
HK (1) | HK1008331A1 (sv) |
HR (1) | HRP950401B1 (sv) |
HU (1) | HU226361B1 (sv) |
IL (1) | IL114477A (sv) |
IS (1) | IS1772B (sv) |
MA (1) | MA23611A1 (sv) |
MX (1) | MX9700358A (sv) |
MY (1) | MY113180A (sv) |
NO (1) | NO312101B1 (sv) |
NZ (1) | NZ289959A (sv) |
PL (1) | PL186342B1 (sv) |
PT (1) | PT773940E (sv) |
RU (1) | RU2157806C2 (sv) |
SA (1) | SA95160294B1 (sv) |
SE (1) | SE504459C2 (sv) |
SI (1) | SI0773940T2 (sv) |
SK (1) | SK284059B6 (sv) |
TN (1) | TNSN95081A1 (sv) |
TR (1) | TR199500861A2 (sv) |
TW (1) | TW372971B (sv) |
UA (1) | UA47409C2 (sv) |
WO (1) | WO1996002535A1 (sv) |
YU (1) | YU49475B (sv) |
ZA (1) | ZA955724B (sv) |
Families Citing this family (153)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
US6875872B1 (en) | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
SE504459C2 (sv) * | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
US6747155B2 (en) | 1997-05-30 | 2004-06-08 | Astrazeneca Ab | Process |
SE510643C2 (sv) * | 1997-06-27 | 1999-06-14 | Astra Ab | Termodynamiskt stabil omeprazol natrium form B |
WO1999001454A1 (en) | 1997-07-03 | 1999-01-14 | Du Pont Pharmaceuticals Company | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
SE9704183D0 (sv) | 1997-11-14 | 1997-11-14 | Astra Ab | New process |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
WO1999038513A1 (en) * | 1998-01-30 | 1999-08-05 | Sepracor Inc. | R-lansoprazole compositions and methods |
AU3967399A (en) * | 1998-04-30 | 1999-11-16 | Sepracor, Inc. | S-rabeprazole compositions and methods |
EP1073332A4 (en) * | 1998-04-30 | 2005-06-15 | Sepracor Inc | R-RABEPRAZOL COMPOSITIONS AND METHODS |
US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
CN1087739C (zh) * | 1998-12-28 | 2002-07-17 | 中国科学院成都有机化学研究所 | 光学纯的苯并咪唑类抗消化性溃疡药物的包结拆分制备法 |
SE9900274D0 (sv) * | 1999-01-28 | 1999-01-28 | Astra Ab | New compound |
TWI275587B (en) | 1999-06-17 | 2007-03-11 | Takeda Chemical Industries Ltd | A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole |
PT1191025E (pt) | 1999-06-30 | 2005-09-30 | Takeda Pharmaceutical | Cristais de lansoprazol |
WO2001014366A1 (fr) * | 1999-08-25 | 2001-03-01 | Takeda Chemical Industries, Ltd. | Procede de preparation de derives optiquement actifs de sulfoxyde |
US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6316020B1 (en) * | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
AU2001252595A1 (en) * | 2000-04-28 | 2001-11-12 | Takeda Chemical Industries Ltd. | Process for producing optically active sulfoxide derivative |
ES2511774T3 (es) | 2000-05-15 | 2014-10-23 | Takeda Pharmaceutical Company Limited | Formas cristalinas de (R)-lansoprazol |
KR100869677B1 (ko) | 2000-05-15 | 2008-11-21 | 다케다 야쿠힌 고교 가부시키가이샤 | 결정의 제조방법 |
WO2002012225A1 (fr) * | 2000-08-04 | 2002-02-14 | Takeda Chemical Industries, Ltd. | Sels de composé à base de benzimidazole et leurs applications |
DK1337525T3 (da) | 2000-12-01 | 2011-09-19 | Takeda Pharmaceutical | Fremgangsmåde til krystallisering af (R)- eller (S)-lansoprazol |
US7064214B2 (en) * | 2001-04-13 | 2006-06-20 | Apsinterm Llc | Methods of preparing sulfinamides and sulfoxides |
GB2376231A (en) * | 2001-06-06 | 2002-12-11 | Cipla Ltd | Benzimidazole-cyclodextrin inclusion complex |
MXPA04007169A (es) * | 2002-01-25 | 2004-10-29 | Santarus Inc | Suministro transmucosal de inhibidores de bomba de protones. |
ES2286408T3 (es) * | 2002-03-05 | 2007-12-01 | Astrazeneca Ab | Sales de alquilamonio de omeprazol e esomeprazol. |
AU2003262375A1 (en) * | 2002-04-22 | 2003-11-03 | Sun Pharmaceutical Industries Limited | Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts |
US7169793B2 (en) | 2002-06-27 | 2007-01-30 | Dr. Reddy's Laboratories Limited | Process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
EP1552833B1 (en) | 2002-10-16 | 2016-12-28 | Takeda Pharmaceutical Company Limited | Process for producing an amorphous optically active isomer of lansoprazole |
EP1556043A1 (en) | 2002-10-22 | 2005-07-27 | Ranbaxy Laboratories, Ltd. | Amorphous form of esomeprazole salts |
DE10254167A1 (de) | 2002-11-20 | 2004-06-09 | Icon Genetics Ag | Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen |
BR0316702A (pt) * | 2002-12-06 | 2005-10-18 | Altana Pharma Ag | xprocesso para preparação de (s)-pantoprazol |
PT1578742E (pt) * | 2002-12-06 | 2013-01-24 | Nycomed Gmbh | Processo para preparar compostos activos opticamente puros |
FR2848555B1 (fr) | 2002-12-16 | 2006-07-28 | Negma Gild | Enantiomere(-)du tenatoprazole et son application en therapeutique |
AR046245A1 (es) * | 2002-12-16 | 2005-11-30 | Ranbaxy Lab Ltd | Sales de calcio de rabeprazol |
WO2004056804A2 (en) | 2002-12-19 | 2004-07-08 | Teva Pharmaceutical Industries Ltd. | Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
WO2004060263A2 (en) * | 2003-01-07 | 2004-07-22 | Ranbaxy Laboratories Limited | Magnesium salt of imidazole derivative |
TWI367759B (en) * | 2003-02-20 | 2012-07-11 | Santarus Inc | A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid |
BRPI0407906A (pt) * | 2003-02-28 | 2006-02-14 | Ranbaxy Lab Ltd | polimorfos de s-omeprazol |
WO2004080961A2 (en) * | 2003-03-12 | 2004-09-23 | Teva Pharmaceutical Industries Ltd. | Crystalline and amorphous solids of pantoprazole and processes for their preparation |
EP1611901B1 (en) * | 2003-03-13 | 2013-07-10 | Eisai R&D Management Co., Ltd. | Preventive or remedy for teeth grinding |
FR2852956B1 (fr) * | 2003-03-28 | 2006-08-04 | Negma Gild | Procede de preparation enantioselective de derives de sulfoxydes |
KR20060002878A (ko) * | 2003-03-28 | 2006-01-09 | 지뎀 파마 | 술폭시화물 유도체의 광학 선택적 제조 방법 |
CN1842525A (zh) * | 2003-05-05 | 2006-10-04 | 兰贝克赛实验室有限公司 | 苯并咪唑衍生物的钡盐 |
CA2528993A1 (en) | 2003-06-10 | 2004-12-23 | Teva Pharmaceutical Industries Ltd. | Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
SE0302382D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts II |
SE0302381D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts I |
AU2003288703A1 (en) * | 2003-12-05 | 2005-06-24 | Hetero Drugs Limited | A process for the preparation of substitited pyridinylmethylsulfinyl- benzimidazole enantiomers |
SE0400410D0 (sv) | 2004-02-20 | 2004-02-20 | Astrazeneca Ab | New compounds |
PT1740571E (pt) | 2004-04-28 | 2009-09-02 | Hetero Drugs Ltd | Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP1748998B1 (en) * | 2004-05-28 | 2010-01-27 | Hetero Drugs Limited | A novel stereoselective synthesis of benzimidazole sulfoxides |
CN1960987A (zh) * | 2004-06-02 | 2007-05-09 | 奥坦纳医药公司 | 制备吡啶-2-基甲基亚磺酰基-1h-苯并咪唑类化合物的方法 |
US8461187B2 (en) | 2004-06-16 | 2013-06-11 | Takeda Pharmaceuticals U.S.A., Inc. | Multiple PPI dosage form |
US20080249134A1 (en) * | 2004-06-24 | 2008-10-09 | Ursula Hohlneicher | New Esomeprazole Sodium Salt Crystal Modification |
NZ551970A (en) * | 2004-06-24 | 2010-01-29 | Astrazeneca Ab | New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt |
FR2876101B1 (fr) * | 2004-10-05 | 2007-03-02 | Sidem Pharma Sa Sa | Procede de preparation enantioselective de derives de sulfoxydes |
DE602005016705D1 (de) * | 2004-10-11 | 2009-10-29 | Ranbaxy Lab Ltd | Verfahren zur herstellung substituierter sulfoxide |
US7592111B2 (en) * | 2004-11-05 | 2009-09-22 | Xerox Corporation | Imaging member |
CA2597632C (en) * | 2005-03-25 | 2012-05-15 | Livzon Pharmaceutical Group Inc. | Substituted sulfoxide compounds, methods for preparing the same and use thereof |
CN101098867B (zh) * | 2005-03-25 | 2010-08-11 | 丽珠医药集团股份有限公司 | 取代的亚砜类化合物和其制备方法及用途 |
WO2006120520A1 (en) * | 2005-05-06 | 2006-11-16 | Glenmark Pharmaceuticals Limited | Esomeprazole strontium salt, process for its preparation and pharmaceutical compositions containing same |
ES2432563T3 (es) * | 2005-06-08 | 2013-12-04 | Lek Pharmaceuticals D.D. | Solvato cristalino de omeprazol sódico |
US20070043085A1 (en) * | 2005-08-19 | 2007-02-22 | Glenmark Pharmaceuticals Limited | Process for the preparation of amorphous form of neutral esomeprazole |
AU2006323245B2 (en) * | 2005-12-05 | 2011-03-03 | Astrazeneca Ab | New process for the preparation of esomeprazole non-salt form |
EP1801110A1 (en) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
DE102005061720B3 (de) * | 2005-12-22 | 2006-10-19 | Ratiopharm Gmbh | Enantioselektive Herstellung von Benzimidazolderivaten und ihren Salzen |
US7553857B2 (en) | 2005-12-23 | 2009-06-30 | Lek Pharmaceuticals D.D. | S-omeprazole magnesium |
ES2325336T3 (es) | 2005-12-28 | 2009-09-01 | Union Quimico-Farmaceutica, S.A. | Procedimiento para la preparacion del enantiomero (s) de omeprazol. |
CN1810803B (zh) * | 2006-02-17 | 2010-11-17 | 中国科学院上海有机化学研究所 | 高对映体选择性制备(s)-奥美拉唑的方法 |
US7579476B2 (en) * | 2006-02-24 | 2009-08-25 | Praktikatalyst Pharma, Llc | Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals |
US8063074B2 (en) * | 2006-05-04 | 2011-11-22 | Dr. Reddy's Laboratories Limited | Polymorphic forms of esomeprazole sodium |
US7786309B2 (en) * | 2006-06-09 | 2010-08-31 | Apotex Pharmachem Inc. | Process for the preparation of esomeprazole and salts thereof |
US8404853B2 (en) | 2006-07-05 | 2013-03-26 | Lupin Limited | Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds |
CA2660112A1 (en) | 2006-08-08 | 2008-02-14 | Jubilant Organosys Limited | Process for producing sulphoxide compounds |
JP5492417B2 (ja) | 2006-10-13 | 2014-05-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 胃酸分泌抑制作用を有するベンズイミダゾール化合物 |
JP2009196894A (ja) * | 2006-10-13 | 2009-09-03 | Eisai R & D Management Co Ltd | スルフィニルベンズイミダゾール化合物またはその塩の製造方法 |
EP1947099A1 (en) | 2007-01-18 | 2008-07-23 | LEK Pharmaceuticals D.D. | Process for solvent removal from omeprazole salts |
EP2125783A2 (en) | 2007-02-21 | 2009-12-02 | Cipla Limited | Process for the preparation of esomeprazole magnesium dihydrate |
WO2008149204A1 (en) * | 2007-06-07 | 2008-12-11 | Aurobindo Pharma Limited | An improved process for preparing an optically active proton pump inhibitor |
CN101323609B (zh) * | 2007-06-15 | 2013-05-01 | 成都福瑞生物工程有限公司 | 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法 |
WO2009066321A2 (en) * | 2007-10-03 | 2009-05-28 | Ipca Laboratories Limited | Process for optically active sulfoxide compounds |
US8106210B2 (en) | 2007-10-08 | 2012-01-31 | Hetero Drugs Limited | Polymorphs of esomeprazole salts |
JP5629581B2 (ja) | 2007-10-12 | 2014-11-19 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | 食物の摂取から独立した消化器疾患の治療方法 |
FR2925899B1 (fr) * | 2007-12-27 | 2012-12-21 | Sidem Pharma Sa | Procede de preparation enantioselective de sulfoxydes. |
CN101492459B (zh) * | 2008-01-25 | 2011-04-27 | 山东轩竹医药科技有限公司 | 含烷氧乙酰基二氢异噁唑并吡啶化合物 |
CN101497603B (zh) * | 2008-01-30 | 2012-11-07 | 山东轩竹医药科技有限公司 | 含有被烷氧烷胺氧基取代的吡啶的苯并咪唑衍生物 |
CL2009000547A1 (es) | 2008-03-10 | 2010-05-07 | Takeda Pharmaceuticals Co | Forma cristalina de (r)-2[[[3-metil-4-(2,2,2-trifluoroetoxi)-2-piridinil]metil]sulfinil]-1h-bencimidazol, metodo de preparacion; composicion farmaceutica y su uso para la profilaxis o tratamiento de ulcera peptica, gastritis, esofagitis erosiva, esofago de barret,dispepsia funcional, cancer gastrico. |
MX2010010049A (es) * | 2008-03-18 | 2010-10-04 | Reddys Lab Ltd Dr | Proceso y polimorfos de dexlansoprazol. |
CN101538264A (zh) * | 2008-03-19 | 2009-09-23 | 中国科学院成都有机化学有限公司 | 手性亚砜类化合物的制备新方法 |
WO2009145368A1 (en) * | 2008-05-27 | 2009-12-03 | Sk Chemicals Co., Ltd. | Improved preparing method of (s)-omeprazole from omeprazole racemate using optical resolution agent |
EP2143722A1 (en) | 2008-07-09 | 2010-01-13 | Lek Pharmaceuticals D.D. | Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
WO2010039885A2 (en) * | 2008-09-30 | 2010-04-08 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of dexlansoprazole |
EP2264024A1 (en) | 2008-10-14 | 2010-12-22 | LEK Pharmaceuticals d.d. | Process for the preparation of enantiomerically enriched proton pump inhibitors |
IT1391776B1 (it) | 2008-11-18 | 2012-01-27 | Dipharma Francis Srl | Procedimento per la preparazione di dexlansoprazolo |
CZ200990A3 (cs) * | 2009-02-16 | 2010-08-25 | Zentiva, K.S. | Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu |
WO2010097583A1 (en) | 2009-02-24 | 2010-09-02 | Cipla Limited | Esomeprazole potassium polymorph and its preparation |
CZ2009172A3 (cs) * | 2009-03-17 | 2010-09-29 | Zentiva, K.S. | Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu |
WO2010150276A2 (en) * | 2009-06-02 | 2010-12-29 | Sun Pharmaceutical Industries Limited | Process for preparing sulphoxide compounds |
IT1395118B1 (it) | 2009-07-29 | 2012-09-05 | Dipharma Francis Srl | Procedimento per la preparazione di dexlansoprazolo cristallino |
WO2011058569A1 (en) | 2009-11-12 | 2011-05-19 | Hetero Research Foundation | Process for the resolution of omeprazole |
CA2788147A1 (en) | 2010-01-29 | 2011-08-04 | Ranbaxy Laboratories Limited | Process for the preparation of crystalline forms of dexlansoprazole |
KR20130087509A (ko) | 2010-06-24 | 2013-08-06 | 씨아이피엘에이 엘티디. | 덱스라베프라졸의 염 및 다형체 |
CN101914090B (zh) * | 2010-08-13 | 2013-03-20 | 埃斯特维华义制药有限公司 | 左旋奥美拉唑的制备方法 |
CN102558150B (zh) * | 2010-12-31 | 2014-03-12 | 正大天晴药业集团股份有限公司 | 取代亚砜化合物的合成方法 |
CN102321071B (zh) * | 2011-07-20 | 2013-01-23 | 江苏奥赛康药业股份有限公司 | 一种高纯度埃索美拉唑钠的工业化生产方法 |
CN102977076A (zh) * | 2011-09-02 | 2013-03-20 | 扬子江药业集团上海海尼药业有限公司 | 一种右兰索拉唑的制备方法 |
CN102329302A (zh) * | 2011-10-22 | 2012-01-25 | 刘强 | 一种埃索美拉唑及其盐的制备方法 |
CN102408412A (zh) * | 2011-10-25 | 2012-04-11 | 广东华南药业集团有限公司 | 高对映体选择性制备(s)- 奥美拉唑的方法 |
CN102432412A (zh) * | 2011-10-28 | 2012-05-02 | 成都欣捷高新技术开发有限公司 | 一种手性亚砜类质子泵抑制剂或其可药用盐的制备方法 |
KR101300950B1 (ko) * | 2011-10-31 | 2013-08-27 | 르노삼성자동차 주식회사 | 전기자동차의 공기 흡입 장치 |
WO2013140120A1 (en) | 2012-03-22 | 2013-09-26 | Cipla Limited | Glycerol solvate forms of (r) - 2 - [ [ [3 -methyl -4 (2,2, 2 - trifluoroethoxy) pyridin- 2 - yl] methyl] sulphinyl] - 1h - ben zimidazole |
CN102633776B (zh) * | 2012-03-28 | 2014-06-18 | 中山市仁合药业有限公司 | 一种埃索美拉唑及其钠盐的制备方法 |
CN102659763B (zh) * | 2012-04-27 | 2014-01-22 | 南京优科生物医药研究有限公司 | 一种右旋兰索拉唑合成与纯化的方法 |
CN103044402B (zh) * | 2012-12-31 | 2015-01-14 | 康普药业股份有限公司 | 埃索美拉唑钠合成生产方法 |
CN103113351B (zh) * | 2013-03-08 | 2015-01-21 | 苏州特瑞药业有限公司 | 一种光学纯手性亚砜类化合物的制备方法 |
CN104177336A (zh) * | 2013-05-28 | 2014-12-03 | 上海汇伦生命科技有限公司 | 一种对映选择性合成右兰索拉唑的方法 |
WO2015155307A1 (en) | 2014-04-11 | 2015-10-15 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Pharmaceutical combinations of rivaroxaban and proton pump inhibitors |
EP2933002A1 (en) | 2014-04-11 | 2015-10-21 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of dabigatran and proton pump inhibitors |
EP2980086B1 (en) | 2014-07-29 | 2016-06-15 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Efficient process for the preparation of esomeprazole (S)-binol complex |
WO2016104668A1 (ja) * | 2014-12-26 | 2016-06-30 | 国立大学法人 東京大学 | 光学活性のプロトンポンプ阻害化合物の製造方法 |
CN104610226A (zh) * | 2014-12-31 | 2015-05-13 | 广东东阳光药业有限公司 | 一种右兰索拉唑的不对称氧化方法 |
ES2615637T3 (es) | 2015-03-06 | 2017-06-07 | F.I.S.- Fabbrica Italiana Sintetici S.P.A. | Procedimiento mejorado para la purificación óptica del esomeprazol |
CN105218391B (zh) * | 2015-07-09 | 2017-11-21 | 天津青松华药医药有限公司 | L‑酒石酸单酯单酰胺类化合物 |
CN105218392B (zh) * | 2015-07-09 | 2017-11-21 | 天津青松华药医药有限公司 | D‑酒石酸单酯单酰胺类化合物 |
CN105968097B (zh) * | 2016-05-17 | 2019-05-03 | 杭州华东医药集团新药研究院有限公司 | 左旋泮托拉唑的工业化生产方法 |
CN106083818A (zh) * | 2016-06-08 | 2016-11-09 | 扬子江药业集团有限公司 | 一种高纯度埃索美拉唑钠的制备方法 |
CN106366070B (zh) * | 2016-08-10 | 2019-06-11 | 上海万巷制药有限公司 | 一种高纯度埃索美拉唑钠的制备方法 |
CN106632249A (zh) * | 2016-09-30 | 2017-05-10 | 青岛云天生物技术有限公司 | 一种制备(s)‑泮托拉唑钠的方法 |
CN106632248A (zh) * | 2016-09-30 | 2017-05-10 | 青岛云天生物技术有限公司 | 一种左旋泮托拉唑钠的制备工艺 |
CN106866630B (zh) * | 2017-04-01 | 2018-08-07 | 上海华源医药科技发展有限公司 | 一种右兰索拉唑的制备方法 |
CN110746428A (zh) * | 2019-10-29 | 2020-02-04 | 株洲千金药业股份有限公司 | 一种r型手性亚砜类化合物的制备方法 |
CN110698482A (zh) * | 2019-10-29 | 2020-01-17 | 株洲千金药业股份有限公司 | 一种s型手性亚砜类化合物的制备方法 |
CN113845510A (zh) * | 2020-06-27 | 2021-12-28 | 鲁南制药集团股份有限公司 | 一种埃索美拉唑的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
DE4035455A1 (de) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
SE504459C2 (sv) * | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
GB9423968D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Resolution |
-
1994
- 1994-07-15 SE SE9402510A patent/SE504459C2/sv not_active IP Right Cessation
-
1995
- 1995-07-03 PT PT95926068T patent/PT773940E/pt unknown
- 1995-07-03 EP EP95926068A patent/EP0773940B2/en not_active Expired - Lifetime
- 1995-07-03 US US08/492,087 patent/US5948789A/en not_active Expired - Lifetime
- 1995-07-03 EE EE9700006A patent/EE03354B1/xx unknown
- 1995-07-03 UA UA97020638A patent/UA47409C2/uk unknown
- 1995-07-03 DE DE69530987T patent/DE69530987T3/de not_active Expired - Lifetime
- 1995-07-03 CA CA002193994A patent/CA2193994C/en not_active Expired - Lifetime
- 1995-07-03 DK DK95926068.8T patent/DK0773940T4/da active
- 1995-07-03 SK SK48-97A patent/SK284059B6/sk not_active IP Right Cessation
- 1995-07-03 BR BR9508292A patent/BR9508292A/pt not_active Application Discontinuation
- 1995-07-03 ES ES95926068T patent/ES2199998T5/es not_active Expired - Lifetime
- 1995-07-03 MX MX9700358D patent/MX9700358A/es unknown
- 1995-07-03 AT AT95926068T patent/ATE242233T1/de active
- 1995-07-03 JP JP50493896A patent/JP3795917B2/ja not_active Expired - Fee Related
- 1995-07-03 SI SI9530676T patent/SI0773940T2/sl unknown
- 1995-07-03 AU AU29948/95A patent/AU688074B2/en not_active Expired
- 1995-07-03 WO PCT/SE1995/000818 patent/WO1996002535A1/en active Search and Examination
- 1995-07-03 KR KR1019970700221A patent/KR100356252B1/ko not_active IP Right Cessation
- 1995-07-03 RU RU97102162/04A patent/RU2157806C2/ru active
- 1995-07-04 TW TW084106875A patent/TW372971B/zh not_active IP Right Cessation
- 1995-07-05 CN CN95194956A patent/CN1070489C/zh not_active Expired - Lifetime
- 1995-07-05 PL PL95318165A patent/PL186342B1/pl unknown
- 1995-07-05 NZ NZ289959A patent/NZ289959A/en not_active IP Right Cessation
- 1995-07-05 HU HU9700108A patent/HU226361B1/hu unknown
- 1995-07-05 CZ CZ0006497A patent/CZ297987B6/cs not_active IP Right Cessation
- 1995-07-06 IL IL11447795A patent/IL114477A/en not_active IP Right Cessation
- 1995-07-10 ZA ZA955724A patent/ZA955724B/xx unknown
- 1995-07-10 MA MA23950A patent/MA23611A1/fr unknown
- 1995-07-11 EG EG57195A patent/EG24534A/xx active
- 1995-07-11 DZ DZ950088A patent/DZ1911A1/fr active
- 1995-07-12 HR HR950401A patent/HRP950401B1/xx not_active IP Right Cessation
- 1995-07-13 TN TNTNSN95081A patent/TNSN95081A1/fr unknown
- 1995-07-14 MY MYPI95001998A patent/MY113180A/en unknown
- 1995-07-14 YU YU47695A patent/YU49475B/sh unknown
- 1995-07-14 TR TR95/00861A patent/TR199500861A2/xx unknown
- 1995-10-07 SA SA95160294A patent/SA95160294B1/ar unknown
-
1996
- 1996-06-28 AR ARP960103398A patent/AR003443A1/es active IP Right Grant
- 1996-12-27 IS IS4406A patent/IS1772B/is unknown
-
1997
- 1997-01-10 FI FI970102D patent/FI117830B/sv active
- 1997-01-10 FI FI970102A patent/FI117672B/sv not_active IP Right Cessation
- 1997-01-14 NO NO19970153A patent/NO312101B1/no not_active IP Right Cessation
-
1998
- 1998-07-17 HK HK98109230A patent/HK1008331A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9402510D0 (sv) | Process for synthesis of substituted 2-(2-pyridinylmethylsulphinyl)-1H-benzimidazoles | |
DE69525840T2 (de) | Herstellung von arthropodiziden oxadiazinen | |
NO972912L (no) | Fremstilling av tabletter som kan deles | |
ATE190222T1 (de) | Verfahren zur herstellung von umhüllten tabletten | |
IL116385A0 (en) | Sulphonamides their manufacture and pharmaceutical compositions containing them | |
DE69529686T2 (de) | Enantiosektive herstellung pharmazeutisch aktiver sulfoxide durch biooxidation | |
FR2692264B1 (fr) | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. | |
DE69530511D1 (de) | Enantioselective herstellung von pharmazeutisch aktiven sulfoxiden durch bioreduktion | |
NO970164L (no) | Anvendelse av tiazol- og tiadiazolforbindelser som D3 - dopaminreseptorligander | |
FI970147A0 (sv) | Triazolföreningar och användning av dem som dopamin-D3-ligander | |
HU9802206D0 (en) | Intravenous thaidomid composition for treating immunological diseases | |
DE69604054D1 (de) | Herstellung von mit enantiomer angereicherten ortho-substituierten alpha, alpha-diaromatischen methanolen | |
DE3579955D1 (de) | Verwendung von hydroxyindolderivaten zur herstellung eines arzneimittels zur senkung des blutdrucks. | |
DE59608211D1 (de) | Verfahren zur umwandlung der achiralen meso-form oder des racemats eines ansa-metallocenkomplexes oder deren mischungen in eines seiner enantiomeren | |
ATE84074T1 (de) | Verfahren zur fermentativen herstellung von 2-(4- hydroxiphenoxi-)propionsaeure. | |
ATE127465T1 (de) | Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen. | |
ATE216702T1 (de) | Silylierungsprocess | |
ATE399876T1 (de) | Chemoenzymatisches verfahren zur stereoselektiven herstellung von optisch-angereicherten phenylglycidate | |
DE59506045D1 (de) | Verwendung von substituierten 6-amino-4h-pyranen | |
ATE159246T1 (de) | Verfahren zur herstellung von (s)-vinyl- und (s)- allenyl-gaba | |
ATE295728T1 (de) | Herstellung von 3-fluoroxindolderivaten | |
YU43530B (en) | Process for obtaining new racemic and optic active 1-(2,4-dichlorophenoxy)-3-(3,4-dimethoxy-beta-phenethyl-amino)-propanol-(2) | |
TH23382A (th) | กรรมวิธีสำหรับสังเคราะห์ซับสทิทิวเทดซัลฟอกไซด์ | |
DE19681129D2 (de) | Verwendung des alpha,alpha-Diphenylessigsäure-4-(N-Methyl-Piperidyl)esters als Spasmoanalgetikum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |